Singapore's EDBI joins US oncology startup Erasca's $200m Series B round

Singapore's EDBI joins US oncology startup Erasca's $200m Series B round

US-based cancer-treatment startup Erasca has raised $200 million in its Series B round led by ARCH Venture Partners and Cormorant Asset Management, the company said in a statement Monday.

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter